Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Kingston Health Sciences Centre has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 examiners and 4 art units, indicating that each matter is assigned through a separate examination channel.
STEADMAN, DAVID J is the busiest identified examiner, with 1 pending matter. The distribution supports application-specific response planning, with portfolio tracking used to coordinate deadlines and claim strategies across the separate units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (25%) |
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| §112 only | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEADMAN, DAVID J | 1 | 57.7% | +30.0% |
| SCHAETZLE, KENNEDY | 1 | 83.6% | +7.8% |
| SALMON, KATHERINE D | 1 | 42.7% | +38.2% |
| JONES, CHRISTINE MICHELLE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18015989 | Methods for Classifying Cancer | SALMON, KATHERINE D | 31d overdue |
| 18585270 | Sequential Mapping of Cardiac Arrhythmia without Fiducial Time Reference | SCHAETZLE, KENNEDY | 54d |
| 17281809 | Prostate Cancer Biomarker Assays | JONES, CHRISTINE MICHELLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18015989 | Methods for Classifying Cancer | SALMON, KATHERINE D | 31d overdue |
| 18874304 | Protease Formulation for Treatment of Toxins | STEADMAN, DAVID J | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| 3792 | 1 |
| 1682 | 1 |
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18874304 | Protease Formulation for Treatment of Toxins | STEADMAN, DAVID J | 1656 | §112 | Non-Final OA | — | Pending | Dec 12, 2024 |
| 18585270 | Sequential Mapping of Cardiac Arrhythmia without Fiducial Time Reference | SCHAETZLE, KENNEDY | 3792 | §101Other | Final Rejection | 54d | Pending | Feb 23, 2024 |
| 18015989 | Methods for Classifying Cancer | SALMON, KATHERINE D | 1682 | §101§102§103 | Non-Final OA | 31d overdue | Pending | Jan 13, 2023 |
| 17281809 | Prostate Cancer Biomarker Assays | JONES, CHRISTINE MICHELLE | 1600 | §103 | Final Rejection | — | Pending | Dec 01, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKingston Health Sciences Centre has 4 pending office actions as of November 2026, spread across 4 art units and 4 examiners.
David J Steadman has the most, with 1 of Kingston Health Sciences Centre's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.